UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Clovis Oncology is implementing good security practices.
Rociletinib is a medication developed to treat non-small cell lung carcinomas with a specific mutation. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
This report shows a preliminary security rating for Clovis Oncology. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The Vendor Security Alliance (VSA) questionnaire was created by a coalition of companies committed ...
The NIST Cybersecurity Framework provides a framework, based on existing standards, guidelines and ...
Compare Clovis Oncology's security performance with other companies